Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours
暂无分享,去创建一个
Jelle O. Barentsz | Emerson Leandro Gasparetto | Leonardo Kayat Bittencourt | J. Barentsz | E. Gasparetto | L. Bittencourt | Luiz Carlos Duarte de Miranda | L. C. Miranda
[1] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[2] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[3] J A Smith,et al. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. , 1997, The Journal of urology.
[4] Hans Garmo,et al. Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.
[5] A. D'Amico,et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Machan,et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. , 2010, AJR. American journal of roentgenology.
[7] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[8] Seymour Rosen,et al. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. , 2003, The Journal of urology.
[9] L. Holmberg,et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. , 1997, Urology.
[10] Thomas Hambrock,et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.
[11] P. Choyke,et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies , 2008, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.
[12] A. Zisman,et al. Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer? , 2007, Urologic oncology.
[13] E. Bergstralh,et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. , 2001, The Journal of urology.
[14] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[15] J. Kirkpatrick. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. , 1998, Journal of insurance medicine.
[16] J. Neil. Measurement of water motion (apparent diffusion) in biologial systems , 1997 .
[17] I. Tuerk,et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. , 2008, European urology.
[18] Jonathan I. Epstein,et al. Recommendations for the reporting of prostate carcinoma , 2007, Virchows Archiv.
[19] Thomas Hambrock,et al. Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative radiology.
[20] K. Hosseinzadeh,et al. Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.
[21] M. Soloway,et al. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. , 2008, Urology.
[22] N. deSouza,et al. MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER : VALUE OF APPARENT DIFFUSION COEFFICIENTS FOR IDENTIFYING MALIGNANT NODULES , 2010 .
[23] S. Verma,et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.
[24] L. Turnbull,et al. Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.
[25] Fernando J. Kim,et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011 .
[26] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[27] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[28] M. Reiser,et al. Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. , 2007, AJR. American journal of roentgenology.
[29] B. Issa,et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[30] S. Fosså,et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.
[31] A. Billis. Percent Gleason grade (4/5) as prognostic factor in prostate cancer diagnosed at transurethral resection. , 2002, International braz j urol : official journal of the Brazilian Society of Urology.
[32] Katsuyoshi Ito,et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.
[33] Fernanda Philadelpho Arantes Pereira,et al. Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. , 2009, AJR. American journal of roentgenology.
[34] Katsuyuki Nakanishi,et al. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: Can ADC values contribute to assess the aggressiveness of prostate cancer? , 2011, Journal of magnetic resonance imaging : JMRI.
[35] Thomas L Chenevert,et al. Diffusion imaging: insight to cell status and cytoarchitecture. , 2006, Neuroimaging clinics of North America.
[36] A W Partin,et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.
[37] A. Qayyum. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[38] 佐藤 千峰,et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2006 .
[39] Michael W Kattan,et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Michael W Kattan,et al. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. , 2007, Radiology.
[41] Junqian Xu,et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans , 2009, Magnetic resonance in medicine.
[42] M. Filippi,et al. Basic concepts of advanced MRI techniques , 2008, Neurological Sciences.